Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Study sponsor: RenovoRx

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.